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ABSTRACT 
Prescription stimulant misuse is a growing problem among college students. 
Students found to be at greatest risk for misusing prescription stimulants are those 
who are male, Caucasian, members of a fraternity or sorority, and who have a lower 
grade point average (GPA). The primary reason reported for stimulant misuse among 
college students is academic enhancement. Preliminary findings investigating 
executive functioning (EF) in college students has revealed that individuals with 
deficits in EF are more likely to have educational difficulties and take part in risky 
behavior, and that executive functions are substantially improved in students with 
attention-deficit/hyperactivity disorder and EF deficits when taking prescription 
stimulants. It is possible that students who have greater difficulty with planning, 
organization, self-motivation, and interference control (i.e., EF deficits) are misusing 
prescription stimulants to help them overcome these deficits to succeed academically. 
Therefore, the purpose of the present study was to examine the relationship between 
prescription stimulant misuse, EF, and academic outcomes among a sample of college 
students. Results revealed 18.8% of the sample reported misusing prescription 
stimulants. In addition, participants with clinically significant EF deficits reported 
significantly higher rates of misuse, compared to those without deficits in EF. 
Prescription stimulant misuse, however, did not moderate the relationship between EF 
and GPA. The present findings have implications for identifying sub-populations of 
college students who may be at risk for misusing prescription stimulants and to 
improve prevention and intervention strategies aimed at reducing misuse. Limitations 
and suggestions for future research are discussed.  
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INTRODUCTION 
Prescription stimulant misuse, defined by Weyandt et al. (2014) “as the use of 
stimulant medication in the absence of a valid prescription and use of prescription 
stimulants other than as prescribed” (p.225), is a growing problem among college 
students. Research suggests that 5.3% (Dupont et al., 2008; Poulin 2001) to 43% 
(Benson et al., 2015; DeSantis, Webb & Noar, 2008; Weyandt et al., 2013a; 2014) of 
college students have misused prescription stimulant medication in their lifetime. 
Students found to be at greatest risk for misusing are those who are male, Caucasian, 
members of a fraternity or sorority and who have a lower grade point average (GPA; 
DuPaul et al. 2009; Dussault & Weyandt, 2013; Rabiner et al., 2009). Although those 
with a lower than average GPA have been found to be at a heightened risk for misuse, 
the academic consequences of misusing are largely unknown. Furthermore, research 
also suggests deficits of executive functioning (EF) are associated with lower 
academic achievement (Biederman et al., 2006) and increased likelihood of engaging 
in risky behaviors (Pharo et al., 2011). It seems possible, therefore, that some students 
who struggle academically may have problems with EF and are using prescription 
stimulants to overcome EF deficits to succeed academically. 
ADHD and Prescription Stimulant Use among Students 
Stimulants such as Adderall and Ritalin are frequently prescribed for the 
treatment of attention-deficit/hyperactivity disorder (ADHD), a disorder characterized 
by clinically significant difficulties with inattention, impulsivity and/or hyperactivity. 
ADHD is estimated to affect 3 - 7% of the school-aged population and 2.5 - 4.4% of 
the adult population (American Psychiatric Association, 2013; Kessler et al., 2006). 
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This chronic and pervasive disorder, contrary to popular belief, is not outgrown by 
adulthood and typically persists across the lifespan (Wilens, Farone, & Biederman, 
2004). Interestingly, it is estimated that approximately 2% to 5% of college students 
report clinically significant levels of ADHD symptomatology (DuPaul et al., 2001; 
Janusis & Weyandt, 2010; Pryor et al. 2010; Weyandt et al., 2013b) and recent 
estimates suggest that 5.9% of incoming college freshman have been diagnosed with 
ADHD (Eagan et al., 2014). Research has repeatedly found that college students with 
ADHD have poorer academic functioning compared to their non-diagnosed peers. 
Heiligenstein et al. (1999) found that college students with ADHD had a significantly 
lower mean GPA, were more likely to be on academic probation, and reported 
significantly more academic problems compared to a non-ADHD. A recent study 
conducted by Weyandt et al. (2013b) found that college students with ADHD reported 
significantly lower grades on course assignments than non-ADHD control 
participants. Research has also found that college students with ADHD had 
significantly lower high school and college GPA, ACT scores, and withdrew from 
significantly more classes than did non-ADHD students (Advokat, Lane, & Luo, 
2011) and were less likely to graduate from college (Murphy, Barkley, & Bush, 2002).  
For individuals who have ADHD, a plethora of research supports that 
stimulant medications can be an effective treatment (eg. Kolar et al., 2008; Weyandt, 
2006). In 2011, nearly 14 million monthly prescriptions for ADHD were written for 
Americans ages 20-39 - two and a half times the amount written only four years earlier 
(Schwarz, 2013). Corresponding with the growing number of prescriptions written for 
stimulant medications, however, is a growing problem of misuse of these medications, 
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i.e., using stimulant medication without a valid prescription or other than as 
prescribed. Specifically, studies have found between 2.3% to 4.1% lifetime prevalence 
for prescription stimulant misuse among high school students (Boyd, McCabe, 
Cranford, & Young, 2006; McCabe, Teter, & Boyd, 2004) and between 5.3% (Dupont 
et al., 2008; Poulin 2001) to 43% (Benson et al., 2015; DeSantis et al., 2008; Weyandt 
et al., 2013a) of college students have reported misusing prescription stimulants during 
their lifetime. 
Prevalence, Risk Factors and Motivations of Prescription Stimulant Misuse 
Numerous studies have documented that prescription stimulant misuse is a 
growing problem among college students and that these medications are easily 
accessible on college campuses. Studies consistently indicate that students commonly 
obtain stimulants from peers and friends (DeSantis et al., 2008; Garnier et al., 2010; 
McCabe et al., 2006; McNiel et al., 2011; Weyandt et al., 2013a). The first study to 
assess prescription stimulant misuse was conducted in 2000 by Babcock and Byrne, 
which reported that 16.4% of college students at a northeastern university endorsed 
taking methylphenidate (MPH) for nonmedical purposes. More recent studies 
exploring the misuse of prescription stimulants have reported prevalence rates among 
college students that range from 5.3% to 43% (Benson et al., 2015; DeSantis et al., 
2008; Dupont et al., 2008; Weyandt et al., 2013a). For example, Garnier et al. (2010) 
examined the prevalence of prescription medication diversion (defined as sharing, 
selling, or trading to others who do not have a prescription) among college students 
and found the most commonly diverted medication were prescription ADHD 
medications (61.7% diversion rate). Similarly, Gallucci et al. (2015) found 58.9% of 
 5 
 
college students with a current prescription had diverted their stimulant medication 
during their lifetime and 32.4% had done so during the previous 30 days. Research has 
found a higher rate of stimulant misuse associated with college students who are 
Caucasian, male, members of sororities or fraternities and who have a lower GPA 
(DuPaul et al., 2009; Dussault & Weyandt, 2013; Rabiner et al., 2009). A number of 
psychological risk factors have been associated with prescription stimulant misuse, 
including symptoms of inattention (Arria et al., 2011; Rabiner et al., 2009), anxiety, 
stress, internal impulsivity, and internal restlessness (Dussault & Weyandt, 2013). 
Indeed, a recent meta-analysis found ADHD symptoms were significantly associated 
with prescription stimulant misuse (Benson et al., 2015). Further, Van Eck and 
colleagues (2012), found disinhibition and conduct problem symptoms moderated the 
association between ADHD symptoms and misuse of prescription stimulants among 
college students. Researchers have also reported higher rates of prescription stimulant 
misuse among students who engaged in substance use and other risky behaviors such 
as drinking and driving (McCabe et al., 2005). The identification of predictors, such as 
the academic and psychosocial functioning of students, is particularly important for 
prevention and intervention strategies.   
Although the misuse of prescription stimulants among college students is well 
documented, the age at which individuals first start misusing prescription stimulants is 
unclear and in fact, students may begin misusing prescription stimulants prior to 
college. For example, White et al. (2006) conducted a study among college students, 
and found 49% of students reported first misusing prescription stimulants in high 
school and 51% reported first misusing in college. Furthermore, the study found a 
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significant trend of misuse of prescription stimulants by students who attended a 
private high school than by those who had attended a public high school. In a separate 
study, Kroutil et al. (2006) found that individuals between ages 12 and 25 reported the 
highest levels of prescription stimulant misuse in a sample of adolescents and adults. 
A study conducted among medical students found students reported their first use of 
prescription stimulants was in college (57%), followed by medical school (22%) and 
then high school (12%; Emanuel et al., 2013). However, an important question that 
remains unaddressed is whether the age of onset of prescription stimulant misuse is 
related to a student’s academic outcomes (i.e., do students who begin misusing 
prescription stimulants at a younger age have different academic outcomes compared 
to students who begin misusing at older ages or not at all?). The present study 
attempted to address this question. 
Similarly, questions remain regarding the potential relationship between 
frequency of misuse and academic outcomes. Preliminary studies suggest that a wide 
range of frequency of prescription stimulant misuse exists; however, whether 
frequency of misuse is related to academic outcomes has been unexplored. Regarding 
frequency, White et al. (2006) found that 15.5% of college students who reported 
misusing prescription stimulants did so 2 to 3 times per week, approximately half of 
students (50.6%) did so 2 to 3 times per year and 33.9% of students did so 1 to 2 times 
per month. A separate study also conducted among college students, found that 44.0% 
of students who had misused prescription stimulants had only done so once or twice in 
their lives, and the majority (85.3%) had used fewer than 12 times (Arria et al., 
2008b).  
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Recently, a meta-analysis conducted by Benson and colleagues (2015) found 
that of 15 studies that asked about motives for misuse, all of them reported that the 
most commonly endorsed reasons were for academics. Similarly, a recent systematic 
review by Weyandt et al. (2013a) found that 15 of 18 relevant studies identified the 
primary motivation of college students misuse was for academic/cognitive reasons. 
For example, Bossaer et al. (2013) found the top reason for prescription stimulant 
misuse was to enhance alertness/energy (65.9%), followed by to improve academic 
performance (56.7%) among students at an academic health sciences center. 
Furthermore, Weyandt et al. (2009) found the highest reported reasons for stimulant 
misuse among a sample of college students was to perform better on schoolwork, 
perform better on tests and focus better in class. Judson and Langdon (2009) also 
identified the primary motivations for misuse were to improve concentration and to 
increase alertness and further suggested that academic performance pressures 
significantly influence illicit use of prescription stimulants. In summary, research 
investigating prescription stimulant misuse indicates significant numbers of college 
students are misusing prescription stimulants for academic/cognitive enhancement; 
yet, there is a lack of information regarding frequency of misuse and academic 
outcomes. 
Prescription Stimulant Misuse and Academic Performance 
Although academic enhancement has consistently been reported as the primary 
motive for students to engage in misuse of prescription stimulants, studies have found 
misuse to be negatively associated with academic performance (Advokat et al., 2008; 
McCabe et al., 2005; Weyandt et al., 2009). For example, Arria et al. (2008) 
 8 
 
conducted a study among first-year college students and found that those who engaged 
in misuse of prescription stimulants had poorer study skills (e.g., skipped classes more 
often, spent less time studying, and more time socializing) and poorer academic 
performance (e.g., lower GPAs in high school and college) compared to those who 
had never misused. Furthermore, results indicated past-year misuse of prescription 
stimulants predicted lower GPA by the end of the first year of college, which was 
mediated by skipping class (Arria et al., 2008). Procrastination and difficulty with time 
management have also been shown to relate to stimulant misuse among college 
students (Moore et al., 2014).  
In addition to students with low GPAs being among those at the highest risk 
for misuse, research suggests that high-achieving students may also be attracted to and 
engage in misuse of prescription stimulants due to the perceived effectiveness in 
increasing alertness and academic productivity. Support for this is provided by studies 
that have found the prevalence rates of prescription stimulant misuse were higher at 
colleges with more restrictive admissions (McCabe et al., 2005). Specifically, McCabe 
et al. (2005) examined the prevalence rates of prescription stimulant misuse among 
students from 119 nationally represented 4-year colleges in the United States and 
found the aggregate past year prevalence rates of misuse at individual colleges ranged 
from 0% to 25%, with 12 schools having a prevalence of 10% or higher. More than 
80% of those schools with a prevalence of 10% or higher had highly competitive 
admissions standards. Medical students have also been suggested to be at high risk for 
misusing prescription stimulants. Tuttle et al. (2010) found 10% of medical students 
reported using stimulants to improve academic performance. Similarly, the misuse of 
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prescription stimulants appears to be high among student pharmacists (6.7%; Lord et 
al., 2003) and dental and dental hygiene students (12.4%; McNiel et al., 2011).  
Collectively, research indicates significant numbers of students are misusing 
prescription stimulants to enhance their academic performance. Students who perceive 
themselves as struggling academically (i.e. receiving low grades, having difficulty 
attending class and studying) appear to be particularly vulnerable to misuse. Indeed, 
researchers have suggested “students may turn toward ADHD medication in an effort 
to treat their attention difficulties” (Rabiner et al., 2008, p. 10). Given the fact that EF 
skills are necessary for time management, organization, problem solving and 
motivation, all of which are critical abilities for college students to succeed 
academically, it is plausible that students experiencing deficits in EF are using 
prescription stimulants in an effort to self-treat their difficulties. Furthermore, research 
has found that individuals with EF deficits often tend to engage in more risky behavior 
(such as misusing drugs) compared to those without EF deficits (Pharo et al., 2011). 
Although multiple risk factors for misusing prescription stimulants have been 
identified, the possible contribution of EF deficits and academic outcomes has not 
been investigated. 
Executive Functioning among College Students 
Executive functioning (EF) has been defined as “higher-order cognitive 
abilities that allow for strategic planning, cognitive flexibility, self-regulation and 
goal-directed behavior” (Weyandt, 2005, p. 1). EF includes abilities such as 
components of attention, reasoning, planning, inhibition, set-shifting, interference 
control and working memory (Pennington & Orzonoff, 1996; Weyandt & Willis, 
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1994) and are considered critically important for complex human behavior 
(Biederman et al., 2011). Although researchers have found significantly more adults 
with ADHD, compared to non-ADHD participants, suffer from EF deficits, it is 
important to note that EF deficits are not unique to ADHD (Weyandt, 2009; Weyandt 
et al., 2014). For example, individuals with bipolar disorder have been found to 
perform poorly on EF tasks (Dickstein et al., 2004) as well as individuals with 
schizophrenia (Hedge et al., 2013). Irrespective of clinical status, however, deficits of 
EF are associated with lower academic achievement (Biederman et al., 2006). For 
example, Biederman et al. (2006) examined the association between deficits in EF and 
functional outcomes among young adults with ADHD and a comparison non-ADHD 
group and found deficits of EF were associated with lower academic achievement, 
independent of an ADHD diagnosis. The authors suggested “that deficits of executive 
functioning alone cause impairment in educational outcomes, and this is compounded 
by the impairment caused by ADHD” (p. 1736). Similarly, a study conducted by 
Dvorsky and Langberg (2014) found student-rated EF organizational skills and 
motivation longitudinally predicted the overall academic impairment of college 
students with ADHD. Given the demands college students often face, both 
academically and socially, key aspects of EF such as planning, organization and 
inhibition are crucial for their daily life.  
In addition, individuals with EF deficits often also have deficits in response 
inhibition, act impulsively, and fail to consider the consequences of their actions. 
Thus, they tend to engage in more risky behavior (such as misusing drugs) compared 
to those without EF deficits (Pharo et al., 2011). Indeed, Janusis and Weyandt (2010) 
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found that college students with higher rates of sensation seeking were more likely to 
misuse prescription stimulants. Furthermore, a recent study by Langberg et al. (2015) 
found that EF deficits in self-motivation mediated the relationship between ADHD 
symptoms and negative consequences of alcohol use among a sample of college 
students. Given the impaired abilities of students suffering from EF deficits, it follows 
that they may be at a heightened risk to engage in prescription stimulant misuse in 
college. Clearly, further research is needed to evaluate a possible role that EF plays in 
prescription stimulant misuse and academic outcomes. Specifically, if students with 
EF deficits are found to be more at risk to misuse, efforts could be made to identify 
those students and provide them with appropriate support and education. 
Prescription Stimulants and Executive Function 
Recent studies suggest that prescription stimulants are effective in not only 
reducing ADHD symptoms but may improve executive function in individuals 
diagnosed with ADHD. For example, the prescription stimulants methylphenidate and 
amphetamine/D-amphetamine have been associated with improved EF performance in 
children with ADHD and EF impairments (Kempton et al., 1999). Specifically, 
Kempton et al. (1999) used computerized neuropsychological tests to assess EF in 30 
children with ADHD (15 stimulant-naive and 15 stimulant-medicated) and 15 
controls. Results indicated that the stimulant-naive ADHD children were impaired on 
tasks of EF, including planning ability, movement time, attentional set shifting and 
spatial working memory. In comparison, the group of medicated children with ADHD 
showed no impairment on any EF tasks except for deficits in spatial recognition 
memory. More recently, the first double-blind, placebo-controlled, crossover study 
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conducted with college students with ADHD found the stimulant medication, 
lisdexamfetamine dimesylate (LDX) was associated with significant improvement in 
both EF and ADHD symptoms (DuPaul et al., 2012). The study examined the effects 
of LDX in 24 students with ADHD compared to 26 students without the disorder who 
did not take LDX. Results from the study revealed LDX was associated with 
statistically significant main effects for specific aspects of EF related to task 
management, planning, organization, study skills and working memory compared to 
nonmedication baseline and placebo. In individuals with ADHD taking LDX, results 
revealed clinically significant reductions in ADHD symptoms, substantial 
improvements in EF, and positive effects of psychosocial functioning. Despite the 
large effect sizes and robust findings in the area of EF, what remains unknown is 
whether prescription stimulants improve EF of individuals, and in particular college 
students without ADHD. Weyandt et al. (2013a) and others have recommended that 
research explore whether prescription stimulants are truly neurocognitive enhancers. A 
recent study by Ilieva et al. (2013), found Adderall to have no more than small effects 
on cognition in a study of 46 healthy young adults, yet users believed the drug 
enhanced their performance. 
Currently, the findings are mixed with regard to the effectiveness of 
prescription stimulants as neurocognitive enhancers. A recent meta-analysis 
(Marraccini, 2015) found that ADHD medication may act as a neuorocognitive 
enhancer, but only for specific domains of cognition. A review regarding the use of 
prescription stimulants for cognitive enhancement by Smith and Farah (2011) reported 
effects of prescription stimulants on executive functions of working memory and 
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cognitive control were mixed but have been found for some individuals on some tasks. 
Furthermore, the authors concluded prescription stimulants might have positive effects 
on learning for healthy adults. Similarly, a review by Advokat (2010) concerning 
cognitive effects of amphetamine and MPH in ADHD and non-ADHD individuals had 
mixed findings. Studies of adults without ADHD suggest prescription stimulants do 
not promote acquisition of new information or facilitate cognitive plasticity but they 
might improve retention of previously acquired information and facilitate memory 
consolidation (Advokat, 2010). It is not clear, however, if improvement occurs only 
for those having a baseline deficit in EF. A recent study found that MPH did not have 
an overall enhancing effect on attention in healthy adults but suggested that perhaps 
MPH enhances specific cognitive processes that were not assessed in their study (Ter 
Huurne et al., 2015). Recently, Weyandt and colleagues (2014) conducted a systematic 
review of the literature and found pro-stimulants were associated with improvement in 
EF tasks and some domains of cognition for adults including college students. 
Although science has not fully addressed the issue of whether stimulants are 
neurocognitive enhancers for those without ADHD, it is clear that college students 
without ADHD are misusing prescription stimulants for academic purposes and that 
the rates of misuse are continuing to rise (Benson et al., 2015; Rabiner, 2013; Smith & 
Farah, 2011; Weyandt et al., 2013a). 
Purpose of the Study 
 Previous research has found that a significant number of college students in the 
USA and abroad are misusing prescription stimulant medication (Benson et al., 2015; 
Jensen, Forlini, Partridge, & Hall, 2016). Students who are at greater risk for misusing 
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prescription stimulants include those who are white, have low GPAs, and are members 
of fraternities and sororities (Dussault & Weyandt, 2013; Rabiner et al., 2009). The 
primary reason reported for stimulant misuse among college students is academic 
enhancement i.e., to perform better on schoolwork, perform better on tests and focus 
better in class (DeSantis et al., 2008; Dussault & Weyandt, 2013; Graff Low & 
Gendaszek, 2002; Judson & Langdon, 2009; Lookatch et al., 2012; Rabiner et al., 
2009; Weyandt et al., 2009). It is possible that students who have greater difficulty 
with planning, organization, self-motivation, and interference control (i.e., EF deficits) 
are misusing prescription stimulants to help them overcome these deficits to succeed 
academically. Preliminary findings investigating EF in college students has revealed 
that individuals with deficits in EF are more likely to have educational difficulties and 
take part in risky behavior, and that executive functions are substantially improved in 
students with ADHD when taking prescription stimulants (Dupaul et al., 2012; 
Kempton et al., 1999). To date, however, no study has investigated the relationship 
between prescription stimulant misuse, EF, and educational outcomes among college 
students. Results from such a study would be useful in designing prevention and 
intervention programs. Therefore, the purpose of the present study was to examine the 
relationship between prescription stimulant misuse, EF and academic outcomes in a 
large sample of college students from five regions of the United States.
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Specifically, it was hypothesized that: 
1) Students who self reported EF deficits would be more likely to report 
misusing prescription stimulants than students who self reported normal EF skills (i.e., 
no EF deficits as measured by the total score on the Barkley Deficits in Executive 
Functioning Scale).  
2) Students who reported below or above average academic outcomes would 
be more likely to report misusing prescription stimulants than students who reported 
average academic outcomes (average referring to C GPA; 2.0 on a 4.0 scale). 
3) Prescription stimulant misuse would moderate the relationship between EF 
and academic performance. Specifically, prescription stimulant misuse was expected 
to alter the strength and/or direction of the relationship between EF and academic 
performance. 
A secondary purpose of this study was to explore the onset of prescription 
stimulant misuse, frequency of misuse, and academic outcomes. It was predicted that 
the earlier the onset (pre-college) and the greater the frequency of prescription 
stimulant misuse, the more likely students would report lower academic outcomes i.e., 
it was hypothesized that there would be a negative correlation between years of 
prescription stimulant misuse and frequency, and academic performance.  
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METHODS 
Procedures 
The current study was approved by University of Rhode Island Institutional 
Review Board (IRB). University staff and faculty from six public universities located 
in regions of the United States: Northeast, Southeast, Central-Midwest, Northwest and 
Southwest were contacted via email with a description of the proposed study and a 
request to help with recruitment of participants. Schools from various regions were 
included in order to obtain a diverse, geographically representative sample of 
participants. Reported demographics of each university from the 2015-2016 Common 
Data Set (CDS) is included in Appendix F. Faculty and staff were asked to distribute 
the email containing the link to students who may be eligible and willing to 
participate. To further facilitate participant recruitment, the same information was 
posted on public university Facebook webpages. Interested participants were 
instructed to enter a secure and encrypted site and instructed to confirm they had read 
and understood the content by checking a statement of endorsement. The consent form 
(Appendix A) contained the researchers’ contact information should participants have 
had questions or concerns and listed the requirements and responsibilities of 
participating in the study, including a description of the research project, as well as 
any potential for harm, confidentiality and benefits of participating. Participants were 
made aware that the survey was completely voluntary and anonymous and that they 
had the opportunity to discontinue participation in the study at any time. Participants 
who provided consent were presented with electronic versions of three measures, each 
of which is described in detail below: a demographic survey designed by researcher, 
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Stimulant Survey Questionnaire (SSQ; Weyandt et al., 2009) and Barkley Deficits in 
Executive Functioning Scale for Adults (BDEFs for Adults; Barkley, 2011). After 
completing all measures, students were debriefed and provided with information 
regarding how to contact the researcher directly if desired.  
Participants 
A total of 314 individuals completed the survey between November 2015 and 
March 2016. The present sample included N = 308 undergraduate participants from 
six public US universities. The remaining six participants reported being of graduate 
student status (n = 5), or reported attending a university not included in the study (n = 
1). Sample size was calculated a priori based on the primary aim of the study. A power 
analysis using G Power 3.1 (Faul, Erdfelder, Lang, & Buchner, 2007) indicated a 
sample size of at least 128 is estimated to achieve 80% power to detect a medium 
effect size and assuming an alpha of .05. Thus, the sample size of the present study is 
sufficient. 
The mean age of participants was 20.77 years (SD = 3.59; range 18-57 years). A 
little over half of the participants were enrolled at a university in the Northeastern 
United States (52.6%), 19.2% were enrolled at a university in the Central-Midwest, 
18.2% were enrolled in a university in the Southwest, 5.8% were enrolled in a 
university in the Northwest, and 4.2% were enrolled in a university in the Southeast. 
The majority of participants were female (73.4%), and 26.6% identified as male. A 
large percentage of participants identified as White (74.0%), 3.6% identified as Black 
or African American, 7.8% identified as Asian, 0.3% identified as American Indian or 
Alaska Native, 1.0% identified as Native Hawaiian or Other Pacific Island and 13.3% 
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selected Other. Further information concerning participant demographics can be found 
in Table 1.  
Measures 
Demographic Information  
A demographics questionnaire (Appendix B) was administered, which included 
questions about age, gender, ethnicity, degree program and current diagnosis of 
ADHD. Students were asked questions related to their academic performance in 
college for example, “What is your cumulative GPA?” “How many hours per week on 
average do you spend studying?” “How many classes do you skip per week?”. 
Stimulant Survey Questionnaire (SSQ) 
 The SSQ (Weyandt et al., 2009) is a 40-item questionnaire that measures the 
use and misuse of prescription stimulant medications in college students (Appendix 
C). Items on the survey are statements with a 5-point Likert-type scale response (1= 
never, 2 = rarely, 3 = occasionally, 4 = frequently, 5 = always) in the first section, and 
a yes-or-no response in the second section. The total score ranges from 40 to 170, with 
a higher score indicating more prescription stimulant medication use and misuse. 
Several additional questions were added to the SSQ to further investigate patterns of 
use related to onset and frequency of misuse (Appendix D). The SSQ has been found 
to have adequate internal consistency with a Cronbach’s alpha coefficient of .85. 
(Weyandt et al., 2009). Based on factor analysis (Weyandt et al., 2009), the SSQ 
consists of four factors including Self-Reported Prescription Stimulant Misuse, 
Perception of Prevalence of Prescription Misuse among Peers, Knowledge of Atypical 
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Stimulant Misuse among Peers, and Perception of Safety of Stimulants (further 
information regarding the factors is included in Appendix E). The Self-Reported 
Prescription Stimulant Misuse score was used as a continuous outcome variable. For 
group analyses, self-reported prescription stimulant misuse (i.e., those who endorsed 
having misused prescription stimulants and those who did not) was used as a binary 
variable. 
Barkley Deficits in Executive Functioning Scale (BDEFS for Adults)  
 The BDEFS for Adults (Barkley, 2011) is an empirically and theoretically 
based instrument used to evaluate dimensions of adult EF in daily life. The 89-item 
rating scale is intended for adults aged 18-81 years and used to generate a Total EF 
Summary Score, with higher scores indicating higher EF deficiencies thus poorer EF 
skills. Based on factor analysis, the BDEFS consists of five factors: Self-Management 
of Time, Self-Organization and Problem Solving, Self-Restraint, Self-Motivation, and 
Self-Regulation of Emotion. Each item is rated using a four- point scale (1 = never or 
rarely, 2 = sometimes, 3 = often, 4 = very often). The BDEFS for Adults has 
demonstrated good reliability as evidenced by high internal consistency (Cronbach's 
alpha ranging from .91 to .95 scores across the five scales); good inter-observer 
agreement (.66 to .79 across scales); and high test–retest reliability over a 2–3 week 
interval (ranging from .62 to .90 across scales and .84 for the Total EF Summary 
Score). The Total EF Summary Score was used as a continuous variable in correlation 
and regression analyses. For group analyses, clinically significant groups of high EF 
deficits were examined in comparison to the dependent variables. 
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RESULTS 
Data Analyses 
Preliminary assumption testing was conducted following guidelines by 
Tabachnick & Fidell (2007). Data were examined with regard to assumptions of 
unequal sample sizes, missing data, normality, linearity, outliers, homogeneity of 
variance, homogeneity of regression, ratio of cases to independent variables, 
normality, linearity, homoscedasticity, outliers and multicollinearity. Given the group 
endorsing prescription stimulant misuse was much smaller than the group not 
endorsing prescription stimulants, the sample sizes were unequal however they were 
sufficiently large to ensure normality of the sampling distribution (Tabachnick & 
Fidell, 2007). At the individual item level data, missing data ranged from 0% to 1%. 
Missing data were handled using listwise deletion.  
Descriptive Statistics 
Overall prevalence of lifetime prescription stimulant misuse was 18.8%. There 
were not significant differences in misuse based on gender, F (1, 306) = .709, p = 
.401), 17.7% of females reported misusing and 22.0% of males reported misusing. The 
three most frequently reported reasons for prescription stimulant misuse were 
academically related (see Table 4). A substantial number of participants reported 
knowing students who use prescription stimulants while studying (71.4%), during 
finals week (70.5%) and during tests (62.7%). In terms of availability, 44.1% of 
participants agreed that prescription stimulants were easy to get on their campus and 
32.5% neither agreed nor disagreed. With regards to psychological conditions, 
participants reported a diagnosis of anxiety (32.1%), depression (27.6%), eating 
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disorder (7.8%), specific learning disability (3.2%) and 59.4% did not report any 
psychological conditions.  
With regard to EF deficits, based on BDEFs score, 64.6% of participants were in 
the normal range of EF and 35.4% of participants displayed some level of clinical 
significant EF deficits  (see Table 3). With regard to academic outcomes, reported 
GPA ranged from 1.50 to 4.00, the mean equal to 3.29 (SD = 0.48). Only three 
participants reported a GPA below 2.0. Hours spent studying per week ranged from 0 
to 60 hours (M = 14.10, SD = 10.49). Classes skipped per week ranged from 0 to 9 (M 
= 0.47, SD =1.05). In order to standardize classes skipped across varying class 
sessions in schedule, the percent of classes skipped was calculated ([number of class 
sessions skipped/number of class session scheduled] x 100) (Arria et al., 2008). The 
majority of participants reported not skipping any class sessions (72.7%).  
With regard to onset, only 1% of participants reported misusing prescription 
stimulants in elementary school, 2.9% reported misusing prescription stimulants in 
middle/ junior high school, 8.4% reported misusing in high school and 20.5% reported 
misusing in college (see Table 6). It is interesting to note that more participants 
(20.5%) reported misusing specifically in college than when asked about misusing 
prescription stimulants ever (18.8%).  
Prescription Stimulant Misuse and Executive Functioning 
 To test the first hypothesis, that students who reported EF deficits would report 
misusing prescription stimulants more than students who reported normal EF skills 
(i.e., no EF deficits), an independent samples t-test was conducted with the 
independent variable group (EF deficits or no EF deficits; dichotomous) and the 
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dependent variable being the Self-Reported Prescription Stimulant Misuse subscale 
score of the SSQ (continuous). There was heterogeneity of variances, as assessed by 
Levene’s test of homogeneity of variances (p < .001), therefore Welch’s t-test, an 
alternative to the standard t-test, was run in addition to the t-test to account for this 
violation. Results revealed statistically significant group differences according to 
Welch’s t-test, t (143.787) = 4.707, p < .001, Cohen’s d = 0.603. The group with 
clinically significant EF deficits had higher scores on the Self-reported Prescription 
Stimulant Misuse (M = 35.31, SD = 14.56) compared to the group with no clinical EF 
deficiencies (M = 28.24, SD = 7.92). This finding supports the hypothesis and 
indicates students with self reported executive functioning deficits (i.e., lower 
executive functioning skills) were more likely to report misuse of prescription 
stimulants.  
Prescription Stimulant Misuse and Academic Functioning 
 To test the second hypothesis, that students who reported below or above 
average academic outcomes would report misusing prescription stimulants more than 
students who reported average academic outcomes, a logistic regression was 
performed using GPA, hours spent studying and classes skipped as a predictor 
variables. A binomial logistic regression was performed to ascertain the effects of 
GPA, hours spent studying and classes skipped, on the likelihood that participants 
misuse prescription stimulants. To test the assumption of linearity, the linearity of the 
continuous variables with respect to the logit of the dependent variable was assessed 
via the Box-Tidwell (1962) procedure. Based on this assessment, all continuous 
independent variables were found to be linearly related to the logit (logit is the natural 
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logarithm of the odds, it reflects the probability of an event occurring; Cramer & 
Howitt (2004) p. 94) of the dependent variable, thus indicating the assumption of 
linearity was not violated. Outliers were assessed by standardized residuals greater 
than ±2.5 standard deviations; three outliers (standard residual values of 2.606, 2.841 
and 2.936) were identified and included in the analysis. The regression model was 
found not to be statistically significant, χ2(3) = 3.165, p = .367.  
Executive Functioning, Academic Functioning and Prescription Stimulants 
 To test the third hypothesis, that prescription stimulant misuse would moderate 
the relationship between EF and academic outcomes, a two-way between subjects 
ANOVA was performed. Prescription stimulant misuse (dichotomous) and EF groups 
(dichotomous) served as the independent variables and GPA (continuous) served as 
the dependent variable. Assumptions were tested prior to analysis in regard the 
assumption of independence, unequal group size, normality and homogeneity of 
variance. Outliers were assessed by standardized residuals greater than ±3 standard 
deviations; three outliers (standard residual values of -3.56, -3.20 and -3.21) were 
identified and included. The homogeneity of variance was assessed by Levene’s test of 
homogeneity of variance, which was significant at the .05 level [F(3, 301) = 3.321, p = 
.019) indicating violation of this assumption. However, given the interest in the 
possible interaction, no modifications were made. Results revealed, there was a 
significant main effect for EF Clinical group [F(1,301) = 7.316, p = .007, partial η2 = 
.024] but not a statistically significant main effect for misuse on GPA [F(1,301) = 
.019, p = .890, partial η2 = .000]. Furthermore, there was not a statistically significant 
interaction effect [F(1,301) = .194, p = .660, partial η2 = .001], suggesting the effect of 
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EF skills on GPA is the same for those who did and did not misuse prescription 
stimulants.  
Onset and Frequency of Misuse and Academics 
To test the secondary hypothesis that students who reported earlier onset and 
greater frequency of misuse of prescription stimulants would report poorer academic 
outcomes, a multiple regression was performed using age of onset and frequency of 
misuse as predictor variables. GPA served as the dependent variable. There was 
independence of residuals, as assessed by a Durbin-Watson statistic of 1.774 (Durbin-
Watson statistic can range from 0 to 4, a value of approximately 2 indicates that there 
is no correlation between residuals; Cohen et al., 2003). Multicollinearity, which 
occurs when two or more independent variables are highly correlated with each other, 
was not an issue, as assessed by variance inflation factor (VIF) values, which were all 
below 10 (values above 10 are typically considered problematic), and by tolerance 
values, which were all above .10 (values below .10 are typically considered 
problematic; Cohen et al., 2003). The regression model did not statistically 
significantly predict GPA, F (6, 298) = 1.881, p = .084, R2 = .036. Regression 
coefficients and standard errors can be found in Table 9. A multiple regression was 
also conducted, using hours spent studying as the dependent variable. Preliminary 
correlations revealed small negative correlations for onset and frequency of misuse 
and hours spent studying, however only frequency of misuse was found to be 
significant (r = -.134, p = .009). This finding suggests that the more frequently 
prescription stimulants were misused, the less number of hours spent studying. The 
regression model, using onset and frequency as predictor variables and hours spent 
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studying as the dependent variable, was not statistically significant, F (5, 302) = 1.651, 
p = .146).   
Interestingly, descriptive statistical analyses revealed that 7.1% of participants 
agreed with the statement “Using prescription stimulants daily is harmless”, yet 24.7% 
agreed with the statement “Using prescription stimulants occasionally is harmless”. 
Furthermore, higher percentages of misuse were reported for each class year. More 
specifically, only 10.0% of freshman reported misusing prescription stimulants, 14.9% 
of sophomore, 22.4% of juniors and 25.0% of seniors reported misusing prescription 
stimulants.  
Additional Post Hoc Analyses  
Additional post-hoc analyses were conducted to explore potential variations in 
prescription stimulant misuse between universities and possible variations in 
motivations for self-reported prescription use. Specifically, a one-way ANOVA was 
conducted with university geographic region as the independent variable and Self-
Reported Stimulant Misuse subscale of the SSQ as the dependent variable, however 
results were not significant suggesting no differences across universities.  
In addition, preliminary Pearson product-movement correlations were 
calculated to explore relationships between total and subscale scores of the SSQ and 
the BDEFs (see Tables 10-14). Pearson product-moment correlations revealed that 
self-reported stimulant use, as measured by Factor 1 subscale score on the SSQ, was 
significantly correlated with all BDEFs subscales and total score, the strongest 
correlation being with Self-Restraint (r = .513, p < .01), followed by Total EF score (r 
= .421, p < .01), Self-Motivation (r = .400, p < .01), Self-Regulation of Emotions (r = 
 26 
 
.335, p < .01), Self-Organization/ Problem Solving (r = .321, p < .01), and Self-
Management of Time (r=  .280, p < .01). The SSQ Total Score was correlated with all 
the subscales and total score of the BDEFs, the strongest correlation being with Self- 
Restraint (r = .435, p < .01). These findings indicate that students with EF deficits, 
(especially poor self-restraint as measured by the Self-Restraint subscale of the 
BDEFs) are at increased risk to misuse prescription stimulants.  
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DISCUSSION 
A substantial body of research has found that a significant number of college 
students are misusing prescription stimulant medication (Benson et al., 2015; Weyandt 
et al., 2013a). Based on previous findings that suggest that college students are 
misusing prescription stimulants primarily for academic reasons and that executive 
functioning skills are crucial for academic success, the purpose of the present study 
was to examine the relationship between prescription stimulant misuse, EF, and 
academic outcomes A second purpose of this study was to explore the onset of 
prescription stimulant misuse, frequency of misuse, and academic outcomes.  
The study was the first to investigate the relationship between EF and prescription 
stimulant misuse and academic outcomes among a relatively large sample of college 
students from five regions of the USA.  
The first hypothesis that students who reported executive functioning deficits 
would be more likely to report misusing prescription stimulants, as assessed by the 
Self-Reported Prescription Stimulant Misuse factor of the SSQ, than students who 
reported normal EF, as assessed by the BDEFS was supported. Specifically results 
revealed that students with self reported EF deficits had higher scores on the Self-
Reported Prescription Stimulant Misuse factor, indicating greater self reported misuse 
of prescription stimulants. These findings are consistent with previous research 
reporting procrastination and difficulty with time-management were more likely to 
misuse prescription stimulants (Moore et al., 2014) and suggests that students with EF 
deficits are more likely to misuse prescription stimulants than students with normal 
EF. Although not causal, these findings suggest that individuals who have clinically 
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significant EF deficits may be at greater risk for misusing prescription stimulant 
medication. It is unknown if students with EF deficits are benefiting from prescription 
stimulants, or what the effects are on their overall functioning. Prior research has 
suggested that prescriptions stimulants may benefit those suffering from deficits, but 
not improve abilities in healthy individuals not suffering from deficits (Mehta et al., 
2000; Smith & Farah, 2011). Future studies are needed to further understand the 
relationship between EF deficits and prescription stimulants. 
The second hypothesis, that students who reported below or above average 
academic outcomes would be more likely to report misusing prescription stimulants 
than students who reported average academic outcomes was not supported. Results 
revealed, contrary to what was expected, that GPA, hours spent studying and classes 
skipped were not useful in predicting students report of prescription stimulant misuse. 
These findings are consistent with previous research by Advokat and colleagues 
(2008) who also found that GPA was not related to misuse in a study of 1,550 students 
at a public Southern university. However, these findings are inconsistent with studies 
that have found students with lower GPAs to be associated with prescription stimulant 
misuse (Arria et al., 2013; Garnier-Dykstra et al., 2012; Weyandt et al., 2013). It is 
unknown if the GPA of those who reported misusing would be lower had they not 
misused the prescription stimulants. In other words, it is unknown if the prescription 
stimulants were effective in increasing and aiding in academic outcomes, and had the 
students not misused, if their GPAs would be lower. A longitudinal study conducted 
by Arria et al. (2008) found that past-year misuse of prescription stimulants predicted 
lower GPA by the end of the first year of college, which was mediated by skipping 
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class. Given the small percentage of students who reported skipping class, it is 
unknown if this limited the present research findings. Future studies should investigate 
additional academic outcome variables and conduct additional longitudinal research in 
order to better understand the relationship between academic outcomes and 
prescription stimulant misuse. 
The third hypothesis, that prescription stimulant misuse would moderate the 
relationship between EF and academic performance was partially supported. 
Specifically, prescription stimulant misuse was expected to alter the strength and/or 
direction of the relationship between EF and academic performance. As expected, 
participants with EF deficits had lower GPAs. However, results from a two-way 
ANOVA were not statistically significant for an interaction effect. Results were only 
significant for a main effect of EF Clinical group. These findings are consistent with 
previous research that found deficits of EF were associated with lower academic 
achievement (Biederman et al., 2006; Dvorsky & Langberg, 2014) and indicate that 
EF deficits are likely to cause impairment in academic outcomes. Furthermore, the 
effect of EF skills on GPA does not appear to be moderated by prescription stimulant 
misuse. It is unknown if the students reporting EF deficits received any additional 
academic skills assistance (such as time management or study skills assistance), and if 
so, it is unknown how academic skills assistance contributes to the relationship 
between EF, academic outcomes and prescription stimulant misuse. Future studies 
need to further explore the relationship other variables that may be affecting EF 
deficits, academic outcomes and misuse of prescription stimulants.  
Onset and Frequency of Prescription Stimulant Misuse and Academic Outcomes 
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A second purpose of this study was to explore the onset of prescription stimulant 
misuse, frequency of misuse, and academic outcomes. The hypothesis that the earlier 
the onset (pre-college) and the greater the frequency of prescription stimulant misuse, 
the more likely students would be to report lower academic outcomes was not fully 
supported. It was predicted there would be a negative correlation between years of 
prescription stimulant misuse and frequency, and academic performance. Preliminary 
results revealed that while frequency and onset of reported prescription stimulant 
misuse were negatively correlated with hours spent studying, only frequency of 
reported misuse, was statistically significant. These findings are consistent with 
previous research that found college students who misuse prescription stimulants spent 
less time studying (Arria et al., 2008) and suggests that students may be misusing 
prescription stimulants to catch up on studying and cram last minute for an exam. It is 
unknown if students who misuse prescription stimulants more frequently, are actually 
benefitting from the drug and able to get their work done more efficiently, therefore do 
not need to study as long or as has been suggested, it students are misusing 
prescription stimulants to compensate for not studying till the last minute. Results 
from the regression models revealed that frequency and onset of prescription stimulant 
misuse were not statistically significantly in predicting hours spent studying or GPA. 
This finding is inconsistent with longitudinal research that has found misuse of 
prescription stimulants predictive of GPA (Arria et al., 2008). It is unknown the 
effects the prescription stimulants have on the students, it could be that the students 
who misused prescription stimulants were struggling academically when they began 
misusing, and use the drugs to achieve average academic outcomes. Future 
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longitudinal research is needed to determine if frequency and/or onset of prescription 
stimulants misuse are predictive of academic outcomes.  
Furthermore, students appear to perceive occasional use of prescription stimulants 
safer than daily misuse. This finding is consistent with previous research that has 
found college students perceive prescription stimulants as safe (Low & Gendaszek, 
2002) and indicates that students perceive using prescription stimulants once in a 
while (for example, during finals week) is safe. Prior research has reported that 
perceived risk of prescription stimulants is negatively correlated with misuse (Judson 
& Langdon, 2009), i.e. students who reported being more aware of the risks, were less 
likely to report misusing. Future intervention and preventative strategies need to 
educate students on the risks associated with prescription stimulant misuse. 
Consistent with previous research (McCabe, Teter & Boyd, 2004; Austic, 2015), 
participants reported higher rates of misuse while in college than in high school, 
middle/ junior high school and elementary school. Specifically, approximately 3% of 
participants reported misusing in middle/ junior high school and nearly 10% misusing 
in high school. This finding is consistent with previous studies that have reported 
prevalence rates among adolescents that range from 1.7% (Herman-Stahl, Krebs, 
Kroutil, & Heller, 2006) to 8.3% (Whiteside et al., 2015). Studies that were conducted 
among middle school and high schools students reported 2.3% to 4.5% lifetime 
prevalence for prescription stimulant misuse (Boyd, McCabe, Cranford, & Young, 
2006; McCabe, Teter, & Boyd, 2004). In a separate study conducted among high 
school seniors, 7.4% reported misusing Adderall in 2013 and 6.8% reported misusing 
the drug in 2014 (Johnston, OMalley, Miech, Bachman, & Schulenberg, 2015). 
 32 
 
Furthermore, a recent study based on data from 240,160 adolescents and young adults 
(ages 12-20) reported the peak ages to start misusing prescription stimulants are 
between the ages of 16 and 19 (Austic, 2015). Thus, current findings in conjunction 
with previous research suggests that students are misusing prescription stimulants 
prior to college, and it is important that preventative measures are taken aimed at 
middle and high school aged children. Future studies should explore whether motives 
for misuse are different for younger students compared to college students.  
Current results also revealed that reported misuse of prescription stimulant 
medication increased with year in college. More specifically, 10.0% of Freshman, 
14.9% of Sophomores, 22.4% of Juniors, and 25.0% of Seniors reported misusing. 
This finding is consistent with previous studies (DeSantis et al., 2008; McCabe et al., 
2006), and it has been suggested this may be due to upperclassmen having been in 
college longer, therefore had more time and opportunities to misuse. An alternative 
explanation is that upperclassman have more peer pressure and/or academic pressure 
which contribute to their increased rates of misuse.  
Correlational analyses explored the relationships between self-reported 
prescription stimulant misuse and aspects of EF. Analyses revealed that self-reported 
prescription stimulant misuse was correlated with Self-Restraint, Self-Motivation, 
Self-Management of Time, Self-Organization/ Problem Solving, and Self-Regulation 
of Emotions. Although these observed relationships are not causal in nature, it is 
reasonable to consider each as a potential risk factor for prescription stimulant misuse 
among undergraduate students, and to use this information to inform future 
investigations upon which prevention and intervention strategies may be based.  
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Limitations and Future Directions 
Several limitations of the present study should be discussed. First, the current 
study employed a convenience sample, which may limit the generalizability of the 
findings. Second, the sample was disproportionately White and female, which also 
limits the generalizability of the findings. Future research should attempt to acquire a 
more proportionate number of students from various universities. Third, the study was 
voluntary, thus students who participated may not be representative of the entire 
population, as they may have had a special interest in the topics of this survey. Fourth, 
this study relied on self-reported data, and although we have no indication that 
underreporting occurred, due to the sensitive nature of the questions, the possibility of 
response bias and social desirability bias cannot be ruled out. Fifth, as the study was 
correlational in design no causal inferences regarding the relationship between the 
variables of interest can be made.  
Future studies regarding the relationship between prescription stimulant misuse, 
EF and academic outcomes are needed. Ideally, such studies would be longitudinal 
and may benefit from the use of academic outcomes collected directly from the 
universities’ registrar’s office so as to not rely so heavily on self-reported outcomes. 
Future studies should consider including questions that ask about the dosage that 
students are misusing. Future research should also consider including students enrolled 
in private universities as well as community colleges. It is also important that future 
studies consider investigating prescription stimulant misuse and its relationship with 
EF among high school and middle or junior high school students.     
Conclusions 
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In conclusion, this study was the first to investigate the relationship between 
prescription stimulant misuse, EF and academic outcomes among college students. A 
substantial percentage, 18.8%, of college students in this study reported misusing 
prescription stimulants and males and females did not differ in rates of reported 
misuse. The three most frequently reported reasons for prescription stimulant misuse 
were academically related. Additionally, substantial proportions of participants 
reported knowing students who use prescription stimulants for academic reasons. As 
hypothesized individuals identified as having clinically significant levels of EF 
deficits were significantly more likely to report misusing prescription stimulants. 
Participants with EF deficits reported significantly lower GPAs than individuals with 
normal EF, and prescription stimulant misuse was not found to moderate this 
relationship. The present study has many important implications for prevention and 
intervention policies on college campuses, specifically in identifying those at risk for 
misusing prescription stimulants.   
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TABLES 
 
Table 1.1: Participant Demographics 
 
 
 
Category N  Percent 
Gender   
Female 226 73.4% 
Male 82 26.6% 
Race/ Ethnicity   
White 228 74.0% 
Black or African American 11 3.6% 
Asian 24 7.8% 
American Indian or Alaska Native 1 0.3% 
Native Hawaiian or Other Pacific 
Island 
3 1.0% 
Biracial 1 0.3% 
Chican@/Latin@ 1 0.3% 
Hispanic 12 3.9% 
Hispanic/Latino 1 0.3% 
Hispanic/White 2 0.6% 
Human 1 0.3% 
Latina/o 7 2.3% 
Mexican 1 0.3% 
Mexican-American 1 0.3% 
Mixed 2 0.6% 
More than 1 Race 1 0.3% 
Multiracial 1 0.3% 
Non-white 8 2.6% 
Peruvian 1 0.3% 
Class year   
Freshman 60 19.5% 
Sophomore 74 24.0% 
Junior 98 31.8% 
Senior 76 24.7% 
Member of a sorority or fraternity   
Yes 57 18.5% 
No 251 81.5% 
ADHD diagnosis    
Yes 39 12.7% 
No 269 87.3% 
High school   
Public 263 85.4% 
Private 38 12.3% 
Other 7 2.3% 
Intend to purse graduate school   
Yes 247 80.2% 
No 61 19.8% 
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Table 1.2: Participant Demographics- Psychological Conditions 
 
Category N  Percent 
Psychological conditions   
Anxiety 28 9.1% 
Anxiety, Bipolar disorder 1 .3% 
Anxiety, Depression 48 15.6% 
Anxiety, Depression, Bipolar disorder 1 .3% 
Anxiety, Depression, Bipolar disorder, Eating 
disorder 
2 .6% 
Anxiety, Depression, Bipolar disorder, Eating 
disorder, Specific learning disability 
1 .3% 
Anxiety, Depression, Eating disorder 9 2.9% 
Anxiety, Depression, Eating disorder, Specific 
learning disability 
1 .3% 
Anxiety, Depression, Specific learning disability 3 1.0% 
Anxiety, Eating disorder 3 1.0% 
Anxiety, Specific learning disability 2 .6% 
Depression 16 5.2% 
Depression, Eating disorder 3 1.0% 
Depression, Eating disorder, Specific learning 
disability 
1 .3% 
Eating disorder 4 1.3% 
None of the above 183 59.4% 
Specific learning disability 2 .6% 
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 Table 1.3. Participant Demographics- College Major(s) 
 
Category N  Percent 
Business Administration 10 3.2 
Business Administration, Communication and Media 1 .3 
Business Administration, Engineering, Languages and 
Literature 
1 .3 
Business Administration, Humanities and Social Sciences 3 1.0 
Business Administration, Languages and Literature 1 .3 
Business Administration, Mathematics and Computer Science 1 .3 
Business Administration, Natural and Physical Science 1 .3 
Communication and Media 8 2.6 
Communication and Media, Environmental Studies 1 .3 
Communication and Media, Humanities and Social Sciences 1 .3 
Communication and Media, Mathematics and Computer 
Science 
1 .3 
Communication and Media, Natural and Physical Science 1 .3 
Communication and Media, Visual and Performing Arts and 
Design 
1 .3 
Education 10 3.2 
Education, Humanities and Social Sciences 4 1.3 
Education, Political and Global Studies 1 .3 
Engineering 15 4.9 
Engineering, Environmental Studies 1 .3 
Engineering, Healthcare and Clinical Sciences 1 .3 
Engineering, Languages and Literature 2 .6 
Engineering, Mathematics and Computer Science 4 1.3 
Engineering, Natural and Physical Science, Undecided/ 1 .3 
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Engineering, Natural and Physical Science, Undecided/ 
Undeclared 
1 .3 
Environmental Studies 11 3.6 
Environmental Studies, Healthcare and Clinical Sciences 1 .3 
Environmental Studies, Natural and Physical Science 4 1.3 
Environmental Studies, Natural and Physical Science, Visual 
and Performing Arts and Design 
1 .3 
Environmental Studies, Political and Global Studies 1 .3 
Healthcare and Clinical Sciences 82 26.6 
Healthcare and Clinical Sciences, Humanities and Social 
Sciences 
5 1.6 
Healthcare and Clinical Sciences, Natural and Physical Science 3 1.0 
Healthcare and Clinical Sciences, Undecided/ Undeclared 1 .3 
Humanities and Social Sciences 77 25.0 
Humanities and Social Sciences, Natural and Physical Science 3 1.0 
Humanities and Social Sciences, Political and Global Studies 3 1.0 
Languages and Literature 1 .3 
Languages and Literature, Natural and Physical Science 3 1.0 
Languages and Literature, Political and Global Studies 3 1.0 
Mathematics and Computer Science 6 1.9 
Natural and Physical Science 19 6.2 
Natural and Physical Science, Undecided/ Undeclared 1 .3 
Political and Global Studies 7 2.3 
Undecided/ Undeclared 5 1.6 
Visual and Performing Arts and Design 1 .3 
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Table 1.4. Participant Demographics- Age and Academics 
 
 Mean 
Standard 
Deviation Minimum Maximum 
Age 20.77 3.585 18 57 
GPA 3.292 .482 1.50 4.00 
How many class 
sessions are in your 
schedule each week? 
9.80 4.193 1 21 
How many hours per 
week on average do 
you spend studying? 
14.10 10.489 0 60 
How many classes do 
you typically skip per 
week (fill in number of 
classes)? 
.469 1.049 .0 9.0 
Number of hours 
typically spent 
exercising per week 
4.73 4.223 0 23 
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Table 1.5. Participant Demographics- University Regions 
 
Region N Percent 
Northwest 18 5.8 
Southeast 13 4.2 
Southwest 56 18.2 
Central Midwest 59 19.2 
Northeast 162 52.6 
 41 
 
Table 2.1. Prescription Stimulant Misuse: Academic outcomes   
 
 
 
 
Table 2.2. Prescription Stimulant Misuse: Class Year 
 
Have you ever misused a prescription stimulant 
medication? 
No Yes 
 Count Row N % Count Row N % 
Freshman 54 90.0% 6 10.0% 
Sophomore 63 85.1% 11 14.9% 
Junior 76 77.6% 22 22.4% 
Class 
Year 
Senior 57 75.0% 19 25.0% 
 
Have you ever misused a prescription stimulant 
medication? 
No Yes 
 Mean 
Standard 
Deviation Mean 
Standard 
Deviation 
GPA 3.294 .496 3.281 .423 
How many class sessions are in 
your schedule each week? 
9.97 4.216 9.09 4.049 
How many hours per week on 
average do you spend studying? 
14.54 10.815 12.19 8.779 
Standardized Class Sessions 
Skipped 
4.709 10.299 5.933 13.249 
How many classes do you 
typically skip per week (fill in 
number of classes)? 
.406 .9304 .741 1.4334 
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Table 2.3. Prescription Stimulant Misuse: Gender 
 
 
Have you ever misused a 
prescription stimulant 
medication? 
 No Yes Total 
Count 186 40 226 
% within 
Gender 
82.3% 17.7% 100.0% 
% within 
Misused 
stimulant 
medication 
74.4% 69.0% 73.4% 
Female 
% of Total 60.4% 13.0% 73.4% 
Count 64 18 82 
% within 
Gender 
78.0% 22.0% 100.0% 
% within 
Misused 
prescription 
stimulant 
medication 
25.6% 31.0% 26.6% 
Gender 
Male 
% of Total 20.8% 5.8% 26.6% 
Count 250 58 308 
% within 
Gender 
81.2% 18.8% 100.0% 
% within 
Misused a 
prescription 
stimulant 
medication 
100.0% 100.0% 100.0% 
Total 
% of Total 81.2% 18.8% 100.0% 
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Table 3. Executive Functioning Clinical Significance  
 
 
EF Clinical Significance Percent 
Cumulative 
Percent 
EF is not abnormal 64.6% 64.6% 
Marginal clinical significance 6.8% 71.4% 
Borderline or Somewhat Deficient 9.1% 80.5% 
Mildly Deficient 6.5% 87.0% 
Moderately Deficient 8.8% 95.8% 
Markedly Deficient or Severe 4.2% 100.0% 
Total 100.0%  
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Table 4. SSQ Responses Pertaining to the Nature of and Motivations for Self-Reported 
Misuse of Prescription Stimulants 
 
Item  Never Rarely Occasionally Frequently Always 
Total 
endorse 
1. I have used 
prescription 
stimulants for non-
medical purposes. 
77.6% 9.7% 8.8% 2.9% 1.0% 22.4% 
2. I have used 
prescription 
stimulants at parties. 
86.4% 7.5% 3.9% 1.6% 0.6% 13.6% 
3. I have used 
prescription 
stimulants with 
alcohol. 
84.4% 7.8% 5.5% 1.9% 0.3% 15.6% 
4. I have snorted 
prescription 
stimulants. 
89.3% 5.2% 4.2% 1.0% 0.3% 10.7% 
5. I have injected 
prescription 
stimulants. 
98.1% 1.0% 0.6% 0.0% 0.3% 1.9% 
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6. I have smoked 
prescription 
stimulants. 
93.8% 2.9% 1.0% 1.9% 0.3% 7.2% 
7. I have taken 
prescription 
stimulants to focus 
better in class.b 
77.9% 5.8% 6.5% 4.9% 4.9% 22.1%b 
8. I have taken 
prescription 
stimulants to perform 
better on tests.c 
79.5% 6.8% 5.2% 3.9% 4.5% 20.5%c 
9. I have taken 
prescription 
stimulants to help me 
socialize better. 
88.6% 3.9% 4.2% 1.9% 1.3% 11.4% 
10. I have taken 
prescription 
stimulants to help me 
lose weight. 
92.5% 4.2% 2.3% 0.6% 0.3% 7.5% 
11. I have taken 
prescription 
stimulants to perform 
better in my 
schoolwork.a 
75.0% 8.8% 7.5% 3.6% 5.2% 25.0%a 
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12. I have taken 
prescription 
stimulants to feel 
more energetic. 
82.5% 7.1% 6.5% 2.3% 1.6% 17.5% 
13. I have taken 
prescription 
stimulants to feel 
better about myself. 
90.3% 2.6% 3.6% 1.9% 1.6% 9.7% 
14. I have taken 
prescription 
stimulants to “get 
high”. 
87.3% 6.5% 3.6% 2.6% 0.0% 12.7% 
15. I have been 
offered prescription 
stimulants by other 
students. 
59.1% 20.1% 14.0% 5.2% 1.6% 40.9% 
16. I have tried 
someone else’s 
prescription stimulant 
medication. 
80.2% 9.1% 6.5% 2.9% 1.3% 19.8% 
17. I have purchased 
prescription 
stimulants from other 
students. 
88.0% 3.9% 5.5% 1.9% 0.6% 12% 
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18. I have sold 
prescription stimulant 
medication to other 
students. 
93.2% 2.9% 2.3% 1.0% 0.6% 6.8% 
19. I have given 
prescription stimulant 
medication to other 
students. 
88.6% 5.8% 2.9% 1.3% 1.3% 11.4% 
20. I have been 
pressured into letting 
someone else have 
my prescription 
stimulant medication. 
93.5% 3.6% 1.6% 0.6% 0.6% 6.5% 
a Denotes most frequently endorsed reason 
b Second most frequently endorsed reason 
c Third most frequently endorsed reason 
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Table 5. SSQ Responses Pertaining to the Expressed Attitudes and Perceptions of 
Students Regarding Prescription Stimulants 
  
Item 
Strongly 
Disagree Disagree Neutral Agree 
Strongly 
Agree 
21. Prescription stimulants 
are easy to get on this 
campus. 
9.1% 14.3% 32.5% 30.8% 13.3% 
22. Prescription stimulants 
are as easy to get as alcohol. 
14.9% 30.8% 26.9% 21.1% 6.2% 
23. Prescription stimulants 
are as easy to get as 
marijuana. 
12.3% 23.7% 27.3% 26.3% 10.4% 
24. Using prescription 
stimulants occasionally is 
harmless. 
28.9% 25.6% 20.8% 21.8% 2.9% 
25. Using prescription 
stimulants daily is harmless. 
51.0% 29.2% 12.7% 3.9% 3.2% 
26. Prescription stimulant 
use on campus is a problem. 
11.4% 19.5% 37.7% 24.7% 6.8% 
27. Prescription stimulants 
are safer than marijuana. 
44.5% 31.2% 20.1% 3.2% 1.0% 
28. Prescription stimulants 
are safer than alcohol. 
31.5% 28.2% 30.8% 7.5% 1.9% 
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29. I feel I am 
knowledgeable about 
prescription stimulants. 
14.6% 22.4% 25.6% 22.4% 14.9% 
30. I feel I am 
knowledgeable about the 
side effects of prescription 
stimulants. 
18.8% 23.1% 19.5% 24.7% 14.0% 
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Table 6. SSQ Responses Pertaining to Perceived Misuse of Prescription Stimulants 
Among Peers 
 
Item No Yes 
31. I know students who use prescription 
stimulants at parties. 
46.1% 53.9% 
32. I know students who use prescription 
stimulants with alcohol. 
50.6% 49.4% 
33. I know students who use prescription 
stimulants with other drugs. 
52.3% 47.7% 
34. I know students who use prescription 
stimulants while studying. 
28.6% 71.4% 
35. I know students who use prescription 
stimulants during finals week. 
29.5% 70.5% 
36. I know students who use prescription 
stimulants during tests. 
37.3% 62.7% 
37. I know students who snort prescription 
stimulants. 
65.6% 34.4% 
38. I know students who inject prescription 
stimulants. 
91.9% 8.1% 
39. I know students who smoke prescription 
stimulants. 
81.2% 18.8% 
40. I hide my prescription stimulant medication so 
that no one will take it. 
79.9% 20.1% 
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Table 7. SSQ Addendum Responses pertaining to Frequency and Onset 
 
Item Never Rarely Occasionally Frequently Always 
Total 
endorse 
I misused 
prescription 
stimulants in 
elementary school. 
99.0
% 
0.6% 0.3% 0.0% 0.0% 1.0%  
I misused 
prescription 
stimulants in 
middle/ junior high 
school. 
97.1
% 
1.9% 0.0% 1.0% 0.0% 2.9%  
I misused 
prescription 
stimulants in high 
school. 
91.6
% 
6.2% 1.6% 0.3% 0.3% 8.4%  
I have misused 
prescription 
stimulants prior to 
attending college. 
90.6
% 
6.5% 1.9% 0.6% 0.3% 9.4%  
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I have misused 
prescription 
stimulants in 
college. 
79.5
% 
9.7% 7.5% 2.6% 0.6% 20.5% 
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Table 8. Contingency table: Executive functioning and prescription stimulant misuse 
Have you ever misused a 
prescription stimulant 
medication? 
 No Yes Total 
EF is not abnormal 54.9% 9.7% 64.6% 
Marginal clinical 
significance 
5.2% 1.6% 6.8% 
Borderline or Somewhat 
deficient 
7.8% 1.3% 9.1% 
Mildly deficient 
4.9% 1.6% 6.5% 
Moderately Deficient 
6.8% 1.9% 8.8% 
 
 
 
 
EF Clinical 
Significance 
Markedly deficient or 
severe 1.6% 2.6% 4.2% 
Total 81.2% 18.8% 100.0% 
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Table 9. Summary of Multiple Regression Analysis: Onset and Frequency of Misuse, 
GPA 
 
Unstandardized Coefficients 
Standardized 
Coefficients 
 B Std. Error Beta t Sig. 
Intercept 3.648 .225  16.223 .000 
How frequently do you 
misuse prescription 
stimulant medication? 
-.051 .055 -.110 -.932 .352 
I have misused 
prescription stimulants 
prior to attending 
college. 
.071 .124 .072 .572 .568 
I misused prescription 
stimulants in elementary 
school. 
-.105 .273 -.030 -.384 .701 
I misused prescription 
stimulants in middle/ 
junior high school. 
-.207 .117 -.140 -1.768 .078 
I misused prescription 
stimulants in high school. -.043 .136 -.039 -.314 .753 
I have misused 
prescription stimulants in 
college. 
.008 .072 .013 .108 .914 
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Table 10. Correlations of BDEFs and Self-Reported Misuse of Prescription Stimulants 
 
BDEFs 
1  
BDEFs 
2 
BDEFs 
3 
BDEFs 
4 
BDEFs 
5 
BDEFs 
Total 
SSQ 1 
BDEFs 
1 1 .682
** .656** .801** .543** .877** .280** 
BDEFs 
2 .682
** 1 .645** .668** .568** .864** .321** 
BDEFs 
3 .656
** .645** 1 .745** .717** .866** .513** 
BDEFs 
4 .801
** .668** .745** 1 .608** .877** .400** 
BDEFs 
5 .543
** .568** .717** .608** 1 .778** .335** 
BDEFs 
Total .877** .864** .866** .877** .778** 
1 .421** 
SSQ 1 .280** .321** .513** .400** .335** .421** 1 
**. Correlation is significant at the 0.01 level (2-tailed).  
BDEFs1= Section 1 Score: Self-Management of Time; BDEFs 2= Section 2 Score: Self-Organization ‎/ Problem 
Solving; BDEFs 3= Section 3 Score: Self-Restraint; BDEFs 4= Section 4 Score: Self-Motivation; BDEFs 5= 
Section 5 Score: Self-Regulation of Emotions; BDEFs Total= Total EF Summary Score; SSQ 1 = Self-Reported 
Misuse of Prescription Stimulants; SSQ 2 = Perception of Prevalence of Prescription Stimulant Misuse Among 
Peers; SSQ3 = Knowledge of Atypical Stimulant Misuse Among Peers; SSQ 4 = Perception of Safety of 
Prescription Stimulant Medication 
 
Table 11. Correlations of BDEFs and Perception of Prevalence of Prescription 
Stimulant Misuse Among Peers 
 
BDEFs 1  BDEFs 2 BDEFs 3 BDEF 4 BDEFs 5 
BDEFs 
Total 
SSQ 2 -.019 .111 .152** .097 .201** .116
* 
**. Correlation is significant at the 0.01 level (2-tailed).  
*. Correlation is significant at the 0.05 level (2-tailed). 
 
Table 12. Correlations of BDEFs and Knowledge of Atypical Stimulant Misuse Among 
Peers 
 
BDEFs 1  BDEFs 2 BDEFs 3 BDEFs 4 BDEFs 5 
BDEFs 
Total 
SSQ 3 .168** .195** .333** .249** .240** .268
** 
**. Correlation is significant at the 0.01 level (2-tailed).  
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Table 13. Correlations of BDEFs and Perception of Safety of Prescription Stimulant 
Medication 
 
BDEFs 1  BDEFs 2 BDEFs 3 BDEFs 4 BDEFs 5 
BDEFs 
Total 
SSQ 4 .201** .202** .300** .257** .187** .264
** 
**. Correlation is significant at the 0.01 level (2-tailed).  
 
 
Table 14. Correlations of BDEFs and SSQ Total Score 
 
BDEFs 1  BDEFs 2 BDEFs 3 BDEFs 4 BDEFs 5 
BDEFs 
Total 
SSQ 
Total .240
** .320** .435** .350** .308** 
.379** 
**. Correlation is significant at the 0.01 level (2-tailed).  
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APPENDICES 
Appendix A 
Informed Consent 
The University of Rhode Island 
Interdisciplinary Neuroscience Graduate Program  
Prescription stimulant misuse: the relationship between executive functioning and 
academic outcomes 
 
PLEASE PRINT AND KEEP THIS FORM FOR YOURSELF 
 
Dear Participant: 
 
You have been asked to take part in a research project described below. The researcher 
will explain the project to you in detail.  If you have any questions, please feel free to 
contact the student investigator, Bailey Munro, at (401)-580-5959 or 
bailey_munro@uri.edu, or the faculty sponsor, Dr. Lisa Weyandt, at (401)-874-2194 
or lisaweyandt@uri.edu.   
 
The purpose of this study is to examine the misuse of prescription stimulant 
medications and its relation to executive functioning and academic outcomes. 
Responses to survey items are completely anonymous: there will be no identifying 
information linking you to your responses or to any particular organization. The 
survey will take about 15 minutes to complete. Data will be encrypted and stored 
through the website GoogleForms, and only the principal investigator, Dr. Lisa 
Weyandt, and student investigator, Bailey Munro, will have access to the data through 
the use of a password. 
 
YOU MUST BE AT LEAST 18 YEARS OLD to participate in this research project.  
If you are not, please discontinue the survey at this time.   
 
If you decide to participate in this study, it will involve completing some 
questionnaires pertaining to your perceptions about prescription stimulant medication, 
your executive functioning, and your academic functioning.   
 
The possible risks of the study are minimal, although you may feel some 
embarrassment answering questions of a personal nature. Please respond honestly, and 
remember that your responses are anonymous. 
 
Although there are no direct benefits of the study, your answers will help to increase 
knowledge about the complexities of non-prescription stimulant use on college 
campuses. 
 
Your participation in this study is anonymous. This means that your answers to all 
questions are private. No one else can know that you participated in this study, and no 
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one can find out what your answers were to any items. Scientific reports will be based 
on aggregated group data, and will not identify you or any individual in this project. 
 
The decision to participate in this research project is up to you.  You do not have to 
participate, and you can decline to answer the questionnaires. If you decide to take 
part in the study, you may quit at any time. Whatever you decide will in no way 
penalize you or your status as a student. Participation in this study is not expected to 
be harmful or injurious to you. 
 
If you have any additional questions or concerns about this study, you may contact the 
student investigator, Bailey Munro, at (401)-580-5959 or bailey_munro@my.uri.edu, 
or her faculty sponsor, Dr. Lisa Weyandt, at (401)-874-2194, or the University of 
Rhode Island’s Vice Provost for Graduate Studies, Research and Outreach, 70 Lower 
College Road, Suite 2, URI, Kingston, RI; (401)-874-4328. 
 
By clicking this box, you are indicating that: 
You are at least 18 years old.   
You have read the consent form and your questions have been answered to your 
satisfaction. Your completion of the surveys implies your consent to participate in this 
study. 
 
If these questions are upsetting and you want to talk please use the phone numbers below: 
 
The University of Rhode Island Counseling Center     
www.uri.edu/coun     
(401) 874-2288      
Roosevelt Hall, 2nd floor  
 
Florida Atlantic University Counseling and Psychological Services 
http://www.fau.edu/counseling/  
(561) 297-3540 
Student Services Building (SSB #8), Room 229 
 
University of California, Santa Barbara Counseling Center 
http://caps.sa.ucsb.edu   
(805) 893-4411 
Building 599 
 
University of California, Irvine Counseling Center 
http://www.counseling.uci.edu  
(949) 824-6457  
203 Student Services 1 
5500 Campanile Dr. 
 
Central Washington University Counseling Center 
http://www.cwu.edu/medical-counseling/   
(509) 963-1391 
400 E. University Way  
 
The University of Michigan Counseling and Psychological Services 
http://www.umich.edu/~caps/ 
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(734) 764-8312 
Michigan Union, Room 3100 
530 S. State Street 
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Appendix B 
Demographic Questionnaire 
  
1. Current age (in years): ___________ 
 
2. Sex: 
Male 
Female 
Other: __________ 
 
3. Race/Ethnicity (please circle one): 
White 
Black or African American 
Asian 
American Indian or Alaska Native 
Native Hawaiian or Other Pacific Island 
Other: _________ 
 
4a. What university do you currently attend? 
University of Rhode Island 
Central Washington University 
University of Michigan 
Florida Atlantic University 
University of California, Irvine 
University of California, Santa Barbara 
 
4b. Class year (please circle one): 
Freshman  Sophomore Junior  Senior  Other   
 
5. Cumulative Grade Point Average (fill in a number between 0.0 and 4.0): 
__________ 
 
6. How many class session are in your schedule each week? (For example: A class that meets 
Monday, Wednesday and Friday has 3 class session each week): _______________ 
 
7. How many hours per week on average do you spend studying? ________________ 
 
8. How many classes do you typically skip per week? ________________  
 
9. What is your college major(s) (choose interest area)? 
Business Administration 
Communication and Media 
Education 
Engineering 
Environmental Studies 
Healthcare and Clinical Sciences 
Humanities and Social Sciences 
Languages and Literature 
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Mathematics and Computer Science 
Natural and Physical Science 
Political and Global Studies 
Visual and Performing Arts and Design  
Undecided/ Undeclared 
	
10. Are you currently a member of sorority or fraternity?  
 
Yes         No            
 
11. Have you ever been diagnosed with Attention-Deficit-Hyperactivity Disorder 
(ADHD)?     
 
Yes         No            
 
11a. If you answered “yes” to Question 11, with what subtype/presentation of ADHD are 
you diagnosed? 
 
Hyperactive/Impulsive Type 
Inattentive Type  
Combined Type 
Do not know 
Never diagnosed with ADHD 
 
11b. If you answered “yes” to Question 11, at what age were you first diagnosed? 
_______ 
 
12. Are you currently taking stimulant medications including methylphenidate 
(Ritalin, Concerta, Metadate) and amphetamine (Adderall, Dexedrine, Desoxyn) that 
have been prescribed to you by a doctor?    
 
Yes         No  
 
13. Please endorse any of the following psychological conditions that you have previously 
been or are currently diagnosed with: 
 
Anxiety  
Depression  
Bi-polar disorder 
Eating disorder 
Specific learning disability 
 
14. Are you currently registered with the Disabilities Support Services office at your 
university? 
 
Yes         No 
 
15. What type of high school did you attend? 
 Public 
 Private 
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 Other: ______ 
 
16. Do you intend to pursue graduate school (medical, dental, law, masters-degree, PhD) 
upon completion of your bachelors degree?  
 
Yes         No 
 
 
17. Number of hours typically spent exercising per week: ____________ 
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Appendix C 
Stimulant Survey Questionnaire (SSQ) 
Please answer the following questions about your college experience truthfully.  
Stimulants refer to prescription medications including methylphenidate (Ritalin, Concerta, Metadate) 
and amphetamine (Adderall, Dexedrine, Desoxyn). 
Please circle the number that best describes your agreement with each statement. 
 
These questions are rated on a Likert scale:                      Never    Rarely  Occasionally  Frequently  Always 
1.   I have used prescription stimulants for non-medical purposes.  1              2                3                   4                5    
  
2.   I have used prescription stimulants at parties.   1              2                3                   4                5        
3.   I have used prescription stimulants with alcohol.   1              2                3                   4                5     
4.   I have snorted prescription stimulants.    1              2                3                   4                5               
5.   I have injected prescription stimulants.    1              2                3                   4                5    
  
6.   I have smoked prescription stimulants.    1              2                3                   4                5     
7.   I have taken prescription stimulants to focus better in class.  1              2                3                   4                5    
                      
8.   I have taken prescription stimulants to perform better on tests.   1              2                3                   4                5     
9.   I have taken prescription stimulants to help me socialize better.  1              2                3                   4                5   
   
10. I have taken prescription stimulants to help me lose weight.  1              2                3                   4                5    
  
11. I have taken prescription stimulants to perform   1              2                3                   4                5                                     
better in my school work. 
12. I have taken prescription stimulants to feel more energetic.   1              2                3                   4                5     
13. I have taken prescription stimulants to feel better about myself.  1              2                3                   4                5     
14. I have taken prescription stimulants to “get high”.    1              2                3                   4                5   
15. I have been offered prescription stimulants by other students.  1              2                3                   4                5 
16. I have tried someone else’s prescription stimulant medication.   1              2                3                   4                5                
17. I have purchased prescription stimulants from other students.  1              2                3                   4                5                 
18. I have sold prescription stimulant medication to other students.  1              2                3                   4                5                 
19. I have given prescription stimulant medication to other students.  1              2                3                   4                5                     
20. I have been pressured into letting someone else   1              2                3                   4                5    
      have my  prescription stimulant medication.                          
            
 
 
Please answer the following questions about your college experience truthfully.  
Stimulants refer to prescription medications including methylphenidate (Ritalin, Concerta, Metadate) 
and amphetamine (Adderall, Dexedrine, Desoxyn). 
Please circle the number that best describes your agreement with each statement. 
                      Strongly                 Strongly 
These questions are rated on a Likert scale:                           Disagree    Disagree    Neutral    Agree       Agree 
21. Prescription stimulants are easy to get on this campus.  1   2     3     4       5 
22. Prescription stimulants are as easy to get as alcohol.   1   2     3     4       5 
23. Prescription stimulants are as easy to get as marijuana.  1   2     3     4       5 
24. Using prescription stimulants occasionally is harmless.  1   2     3     4       5 
25. Using prescription stimulants daily is harmless.   1   2     3     4       5 
26. Prescription stimulant use on campus is a problem.   1   2     3     4       5 
27. Prescription stimulants are safer than marijuana.   1   2     3     4       5 
28. Prescription stimulants are safer than alcohol.   1   2     3     4       5 
29. I feel I am knowledgeable about prescription stimulants.  1   2     3     4       5 
30. I feel I am knowledgeable about the side effects   1   2     3     4       5     
          of prescription stimulants.  
 
Please Circle Yes or No to the following questions: 
31. I know students who use prescription stimulants at parties.   YES        NO  
32. I know students who use prescription stimulants with alcohol.   YES        NO 
33. I know students who use prescription stimulants with other drugs.   YES        NO 
34. I know students who use prescription stimulants while studying.                       YES        NO  
35. I know students who use prescription stimulants during finals week.  YES       NO  
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36. I know students who use prescription stimulants during tests.   YES       NO  
37. I know students who snort prescription stimulants.    YES       NO 
38. I know students who inject prescription stimulants.    YES       NO  
39. I know students who smoke prescription stimulants.    YES       NO  
40. I hide my prescription stimulant medication so that no one will take it.  YES         NO 
 65 
 
Appendix D 
SSQ Addendum Questions 
 
1. Are you currently prescribed a stimulant medication to treat ADHD?  Yes No 
 If Yes, what medication __________________ 
 
2. Have you ever been prescribed a stimulant medication?   Yes No 
 If Yes, when ______________________ (elementary, middle/junior high school, high school, 
college) 
 
3. Have you ever misused a prescription stimulant medication? Yes No 
If yes, when was the first time ______________________(elementary, middle/junior high 
school, high school, college) 
 
4. Where do you typically obtain stimulant medications?  
Doctor        Friends who share  Friends who sell       I steal them      Family the Internet 
 
5. How frequently do you misuse prescription stimulant medication?  
 Never Once a year Twice a year  Once a month Once a week More than once a week  
   
        Never    Rarely  Occasionally  Frequently  Always 
 
6. I have misused prescription stimulants prior to attending college.           1             2               3                     4               5 
 
 
7. I misused prescription stimulants in elementary school.           1             2               3                     4               5 
 
 
8. I misused prescription stimulants in middle/ junior high school.           1             2               3                     4               5 
 
 
9. I misused prescription stimulants in high school.             1             2               3                     4               5 
 
 
10. I have misused prescription stimulants in college.                    1             2               3                     4               5 
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Appendix E 
Additional Information on the SSQ 
 
Factor 1:   Self-reported prescription stimulant use  
Factor 2:  Perception of prevalence of prescription use among peers  
Factor 3:   Knowledge of atypical stimulant use among peers   
Factor 4:  Perception of safety of stimulants  
 
 Cronbach’s alpha coefficient of .849 for all 40 items of the SSQ. The internal consistency of the four 
factors was as follows: Factor 1 Cronbach’s alpha coefficient = .923; Factor 2 Cronbach’s alpha 
coefficient = .434; Factor 3 Cronbach’s alpha coefficient = .613; and Factor 4 Cronbach’s alpha 
coefficient = .608. 
 
Factor Structure for the Stimulant Survey Questionnaire 
        Factor 
Item                  1  2           3       4___ 
I have used prescription stimulants for non-medical purposes.  .768 
I have used prescription stimulants at parties.    .737 
I have used prescription stimulants with alcohol.    .736  -.302 
I have snorted prescription stimulants.     .673 
I have injected prescription stimulants.       -.632 
I have smoked prescription stimulants.       -.616 
I have taken prescription stimulants to focus better in class.   .834 
I have taken prescription stimulants to perform better on tests.  .854 
I have taken prescription stimulants to help me socialize better.  .520  -.395 
I have taken prescription stimulants to help me lose weight.   .528 
I have taken prescription stimulants to perform better in school work.  .861 
I have taken prescription stimulants to feel energetic.   .825 
I have taken prescription stimulants to feel better about myself  .567 
I have taken prescription stimulants to “get high.”   .501  -.477 
I have been offered prescription stimulants by other students.  .428 -.419 
I have tried someone else’s prescription stimulants.   .758 
I have purchased prescription stimulants from other students.  .746 
I have sold prescription stimulants to other students.   .556 
I have given prescription stimulants to other students.   .581 
I have been pressured into letting someone else have my  
prescription stimulant medication.       
Prescription stimulants are easy to get on this campus.    -.622 
Prescription stimulants are as easy to get as alcohol.    -.533 
Prescription stimulants are as easy to get as marijuana.    -.569 
Using prescription stimulants occasionally is harmless.   .405   .551 
Using prescription stimulants daily is harmless.       .341 
Prescription stimulant use on campus is a problem.    -.362 
Prescription stimulants are safer than marijuana.       .770 
Prescription stimulants are safer than alcohol.       .721 
I feel I am knowledgeable about prescription stimulants.   .405               -.457 
I feel I am knowledgeable about the side effects of  
prescription stimulants.      .341               -.507 
I know students who use prescription stimulants at parties.    .754 
I know students who use prescription stimulants with alcohol.   .723 
I know students who use prescription stimulants with other drugs.   .690 
I know students who use prescription stimulants while studying.   .777 
I know students who use prescription stimulants during finals week.   .780 
I know students who use prescription stimulants during tests.   .763 
I know students who snort prescription stimulants.    .517 
I know students who inject prescription stimulants.  
I know students who smoke prescription stimulants.     .685 
I hide my prescription stimulant medication so that no one will take it.  .356 .600 
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Appendix F 
2015-2016 Common Data Set 
Reported Demographic Information 
 
 
University of Rhode Island 
Gender  
Total Undergraduate Students  13,641 
Male Student Percentage  46% 
Female Student Percentage  54% 
Ethnicity  
Hispanic/Latino 9.45% 
Black or African American  5.21% 
White or Caucasian  69.75% 
American Indian or Alaska Native   0.23% 
Asian  3.22% 
Native Hawaiian or other Pacific Islander  0.03% 
Two or more races  2.77% 
Unknown  7.29% 
 
Florida Atlantic University 
Gender  
Total Undergraduate Students  25,209 
Male Student Percentage  44% 
Female Student Percentage  56% 
Ethnicity  
Hispanic/Latino 25.2% 
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Black or African American  19.16% 
White or Caucasian  44.62% 
American Indian or Alaska Native  0.19% 
Asian  4.2% 
Native Hawaiian or other Pacific Islander 0.12% 
Two or more races 3.19% 
Unknown  1.46% 
 
University of Michigan  
Gender  
Total Undergraduate Students  28,312 
Male Student Percentage  51% 
Female Student Percentage  49% 
Ethnicity  
Hispanic/Latino 4.59% 
Black or African American  4.29% 
White or Caucasian  61.35% 
American Indian or Alaska Native  0.19% 
Asian  12.7% 
Native Hawaiian or other Pacific Islander 0.04% 
Two or more races 3.42% 
Unknown  6.5% 
 
Central Washington University 
Gender  
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Total Undergraduate Students  10,982 
Male Student Percentage  49% 
Female Student Percentage  51% 
Ethnicity  
Hispanic/Latino 13.75% 
Black or African American  3.66% 
White or Caucasian  58.94% 
American Indian or Alaska Native  0.72% 
Asian  4.05% 
Native Hawaiian or other Pacific Islander 0.64% 
Two or more races 6.66% 
Unknown  8.54% 
 
University of California Irvine 
Gender  
Total Undergraduate Students  25,256 
Male Student Percentage  46% 
Female Student Percentage  54% 
Ethnicity  
Hispanic/Latino 24.87% 
Black or African American  1.65% 
White or Caucasian  12.28% 
American Indian or Alaska Native  0.04% 
Asian  37.23% 
Native Hawaiian or other Pacific Islander 0.1% 
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Two or more races 3.79% 
Unknown  4.32% 
 
University of California Santa Barbara 
Gender   
Total Undergraduate Students  20,607 
Male Student Percentage  47% 
Female Student Percentage  53% 
Ethnicity  
Hispanic/Latino 25.92% 
Black or African American  2.2% 
White or Caucasian  35.36% 
American Indian or Alaska Native  0.14% 
Asian  19.48% 
Native Hawaiian or other Pacific Islander 0.13% 
Two or more races 8.4% 
Unknown  1.31% 
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